P1-067: AMBROXOL AS PHARMACOLOGICAL CHAPERONE TARGETING GBA1 AS A DISEASE MODIFYING TREATMENT FOR PARKINSON'S DISEASE DEMENTIA: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
2010 ◽
Vol 9
(10)
◽
pp. 969-977
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 390
(10103)
◽
pp. 1664-1675
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 9
(6)
◽
pp. 573-580
◽
Keyword(s):